Evotec SE (EVO) Cash & Equivalents (2019 - 2026)

Evotec SE has disclosed Cash & Equivalents across 8 years of filings, most recently posting $454146.3 for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $454146.3, up 40.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $454146.3 (up 40.92% YoY), and the FY2025 annual result was $487.17, down 100.0% from the prior year.
• Cash & Equivalents came in at $454146.3 for Q1 2026 at Evotec SE, up from $487.17 in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $549.7 million in Q4 2023 to a low of $487.17 in Q4 2025.
• The 5-year median for Cash & Equivalents is $454146.3 (2026), against an average of $76.7 million.
• Peak annual rise in Cash & Equivalents reached 46.63% in 2022, while the deepest fall reached 100.0% in 2022.
• Evotec SE's Cash & Equivalents stood at $423.6 million in 2022, then advanced by 29.78% to $549.7 million in 2023, then tumbled by 41.13% to $323.6 million in 2024, then sank by 100.0% to $487.17 in 2025, then jumped by 93120.93% to $454146.3 in 2026.
• The last three Cash & Equivalents figures came in at $454146.3 (Q1 2026), $487.17 (Q4 2025), and $209578.8 (Q3 2025), per Business Quant data.